About the role
Queen Mary University of London's Barts Cancer Institute is recruiting a Postdoctoral Research Associate for an ARIA-funded project, "epiPRIME: epigenetically programmed resilience through innate memory engineering." The post-holder will use epigenetic editing techniques engineered in cell lines and primary cells to induce antiviral immunity in human cells, working in a fixed-term laboratory role. Salary is £39,187 to £52,790 per annum.
Requirements include a PhD (or near completion) in a biological subject with significant molecular biology/biochemistry laboratory experience: cloning, cell line and primary cell work, transfections, RNA analysis, epigenomic techniques (targeted or whole-genome bisulfite sequencing, CUT&RUN, CUT&Tag, ChIP-seq or similar), and NGS library preparation, plus first-author publications in epigenetics. R/Python experience is preferred. Applications close 15 November 2026.
Text as published by the employer. Always confirm details on the employer's site.